Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

Mohammad S. Jalali, Ph.D.

Profile Picture


The research activities and funding listed below are automatically derived from NIH ExPORTER and other sources, which might result in incorrect or missing items. Faculty can login to make corrections and additions.
  1. R01CE003358 (JALALI, MOHAMMAD S.) Sep 30, 2021 - Sep 29, 2024
    A community-based systems science approach to assess risk and protective factors and improve the efficacy and equity of intervention strategies for stimulant use, use disorder, and overdose
    Role: Principal Investigator
  2. U01FD007455 (JALALI, MOHAMMAD S.) Sep 1, 2021 - Aug 31, 2022
    Enhancing FDA's opioids systems modeling efforts to more comprehensively address fentanyl, stimulants, polysubstance use, and associated outcomes
    Role: Principal Investigator
  3. 875171 (JALALI) Jan 2, 2021 - Jan 30, 2025
    European Commission
    Monitoring multidimensional aspects of QUAlity of Life after cancer ImmunoTherapy, an Open smart digital Platform for personalized prevention and patient management (QUALITOP)
    Role Description: This project will develop and implement an IT-based European immunotherapy platform and use big data analysis, artificial intelligence, and simulation modeling approaches to collect and aggregate efficiently and effectively real-world quality of life data, monitor patients' health status, conduct causal inference analyses, and create harm-reduction recommendations for patients and other stakeholders.
    Role: Lead Scientist (MGH site)
  4. U01FD007064 (JALALI, MOHAMMAD S.) Sep 1, 2020 - Aug 31, 2021
    Expanding FDA's Opioids Systems Model to Enable Economic Evaluations and Outcome Analyses of National Opioid Policies
    Role: Principal Investigator
  5. 1 U01 FD006868-01 (JALALI) Sep 1, 2019 - Sep 30, 2021
    Using System Dynamics to Enhance the FDA's Opioids Systems Model and Address the Ongoing Crisis
    Role Description: The goal of this project is to enhance and expand the FDA’s current opioid systems model to augment the capabilities of policy and decision makers to curb the opioid crisis. The proposed research will result in a functioning and interactive systems model that can be used to guide policy decisions; insightful policy recommendations at the population level; and multidisciplinary insights to weigh the multiyear benefits and risks of alternative interventions.
    Role: Principal Investigator

Featured Content

Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Faculty can login to make corrections and additions.
Newest   |   Oldest   |   Most Cited   |   Most Discussed   |   Timeline   |   Field Summary   |   Plain Text
PMC Citations indicate the number of times the publication was cited by articles in PubMed Central, and the Altmetric score represents citations in news articles and social media. (Note that publications are often cited in additional ways that are not shown here.) Fields are based on how the National Library of Medicine (NLM) classifies the publication's journal and might not represent the specific topic of the publication. Translation tags are based on the publication type and the MeSH terms NLM assigns to the publication. Some publications (especially newer ones and publications not in PubMed) might not yet be assigned Field or Translation tags.) Click a Field or Translation tag to filter the publications.
  1. Garcia GP, Stringfellow EJ, DiGennaro C, Poellinger N, Wood J, Wakeman S, Jalali MS. Opioid overdose decedent characteristics during COVID-19. Ann Med. 2022 12; 54(1):1081-1088. PMID: 35467475; PMCID: PMC9045762.
    Citations: 1     Fields:    Translation:HumansPHPublic Health
  2. Dong H, Stringfellow EJ, Russell WA, Jalali MS. Racial and Ethnic Disparities in Buprenorphine Treatment Duration in the US. JAMA Psychiatry. 2022 Nov 09. PMID: 36350592; PMCID: PMC9647560.
    Citations:    Fields:    
  3. DiGennaro C, Vahdatzad V, Jalali MS, Toumi A, Watson T, Gazelle GS, Mercaldo N, Lubitz CC. Assessing Bias and Limitations of Clinical Validation Studies of Molecular Diagnostic Tests for Indeterminate Thyroid Nodules: Systematic Review and Meta-Analysis. Thyroid. 2022 Oct; 32(10):1144-1157. PMID: 35999710; PMCID: PMC9595633.
    Citations:    Fields:    Translation:Humans
  4. Stringfellow EJ, Lim TY, Humphreys K, DiGennaro C, Stafford C, Beaulieu E, Homer J, Wakeland W, Bearnot B, McHugh RK, Kelly J, Glos L, Eggers SL, Kazemi R, Jalali MS. Reducing opioid use disorder and overdose deaths in the United States: A dynamic modeling analysis. Sci Adv. 2022 Jun 24; 8(25):eabm8147. PMID: 35749492; PMCID: PMC9232111.
    Citations:    Fields:    
  5. Lim TY, Stringfellow EJ, Stafford CA, DiGennaro C, Homer JB, Wakeland W, Eggers SL, Kazemi R, Glos L, Ewing EG, Bannister CB, Humphreys K, Throckmorton DC, Jalali MS. Modeling the evolution of the US opioid crisis for national policy development. Proc Natl Acad Sci U S A. 2022 06 07; 119(23):e2115714119. PMID: 35639699; PMCID: PMC9191351.
    Citations: 2     Fields:    Translation:HumansPHPublic Health
  6. Beaulieu E, Naumann RB, Deveaux G, Wang L, Stringfellow EJ, Hassmiller Lich K, Jalali MS. Impacts of alcohol and opioid polysubstance use on road safety: Systematic review. Accid Anal Prev. 2022 Aug; 173:106713. PMID: 35640366.
    Citations:    Fields:    Translation:Humans
  7. Garcia GP, Dehghanpoor R, Stringfellow EJ, Gupta M, Rochelle J, Mason E, Pujol TA, Jalali MS. Identifying and Characterizing Medical Advice-Seekers on a Social Media Forum for Buprenorphine Use. Int J Environ Res Public Health. 2022 05 22; 19(10). PMID: 35627818; PMCID: PMC9141384.
    Citations:    Fields:    Translation:Humans
  8. Stafford C, Marrero WJ, Naumann RB, Lich KH, Wakeman S, Jalali MS. Identifying key risk factors for premature discontinuation of opioid use disorder treatment in the United States: A predictive modeling study. Drug Alcohol Depend. 2022 08 01; 237:109507. PMID: 35660221.
    Citations:    Fields:    Translation:Humans
  9. Weiner SG, Carroll AD, Brisbon NM, Rodriguez CP, Covahey C, Stringfellow EJ, DiGennaro C, Jalali MS, Wakeman SE. Evaluating disparities in prescribing of naloxone after emergency department treatment of opioid overdose. J Subst Abuse Treat. 2022 08; 139:108785. PMID: 35537918; PMCID: PMC9187615.
    Citations:    Fields:    Translation:Humans
  10. Liao CY, Garcia GP, DiGennaro C, Jalali MS. Racial Disparities in Opioid Overdose Deaths in Massachusetts. JAMA Netw Open. 2022 04 01; 5(4):e229081. PMID: 35482312; PMCID: PMC9051988.
    Citations:    Fields:    Translation:Humans
  11. Beaulieu E, Spanjaart A, Roes A, Rachet B, Dalle S, Kersten MJ, Maucort-Boulch D, Jalali MS. Health-related quality of life in cancer immunotherapy: a systematic perspective, using causal loop diagrams. Qual Life Res. 2022 Aug; 31(8):2357-2366. PMID: 35298735; PMCID: PMC8929267.
    Citations:    Fields:    Translation:Humans
  12. Cerdá M, Jalali MS, Hamilton AD, DiGennaro C, Hyder A, Santaella-Tenorio J, Kaur N, Wang C, Keyes KM. A Systematic Review of Simulation Models to Track and Address the Opioid Crisis. Epidemiol Rev. 2022 01 14; 43(1):147-165. PMID: 34791110; PMCID: PMC9005056.
    Citations: 1     Fields:    Translation:HumansPHPublic Health
  13. Jalali MS, DiGennaro C, Guitar A, Lew K, Rahmandad H. Evolution and Reproducibility of Simulation Modeling in Epidemiology and Health Policy Over Half a Century. Epidemiol Rev. 2022 01 14; 43(1):166-175. PMID: 34505122; PMCID: PMC8763126.
    Citations: 2     Fields:    Translation:Humans
  14. Xu R, Rahmandad H, Gupta M, DiGennaro C, Ghaffarzadegan N, Amini H, Jalali MS. Weather, air pollution, and SARS-CoV-2 transmission: a global analysis. Lancet Planet Health. 2021 10; 5(10):e671-e680. PMID: 34627471.
    Citations: 7     Fields:    Translation:HumansCellsPHPublic Health
  15. DiGennaro C, Garcia GP, Stringfellow EJ, Wakeman S, Jalali MS. Changes in characteristics of drug overdose death trends during the COVID-19 pandemic. Int J Drug Policy. 2021 12; 98:103392. PMID: 34325184.
    Citations: 10     Fields:    Translation:HumansCellsPHPublic Health
  16. Tatar M, Jalali MS, Tak HJ, Chen LW, Araz OM, Wilson FA. Impact of Florida's prescription drug monitoring program on drug- related fatal vehicle crashes: a difference-in-differences approach. Inj Prev. 2022 04; 28(2):105-109. PMID: 34162702.
    Citations:    Fields:    Translation:Humans
  17. Jalali MS, Landman A, Gordon WJ. Telemedicine, privacy, and information security in the age of COVID-19. J Am Med Inform Assoc. 2021 03 01; 28(3):671-672. PMID: 33325533.
    Citations: 9     Fields:    Translation:Humans
  18. Jalali MS, DiGennaro C, Sridhar D. The need for a prediction model assessment framework - Authors' reply. Lancet Glob Health. 2021 04; 9(4):e405. PMID: 33581048.
    Citations:    Fields:    Translation:HumansCells
  19. Toumi A, DiGennaro C, Vahdat V, Jalali MS, Gazelle GS, Chhatwal J, Kelz RR, Lubitz CC. Trends in Thyroid Surgery and Guideline-Concordant Care in the United States, 2007-2018. Thyroid. 2021 06; 31(6):941-949. PMID: 33280499; PMCID: PMC8215427.
    Citations: 3     Fields:    Translation:Humans
  20. Jalali MS, Ewing E, Bannister CB, Glos L, Eggers S, Lim TY, Stringfellow E, Stafford CA, Pacula RL, Jalal H, Kazemi-Tabriz R. Data Needs in Opioid Systems Modeling: Challenges and Future Directions. Am J Prev Med. 2021 02; 60(2):e95-e105. PMID: 33272714.
    Citations: 6     Fields:    Translation:HumansPHPublic Health
  21. Gupta M, Bansal A, Jain B, Rochelle J, Oak A, Jalali MS. Whether the weather will help us weather the COVID-19 pandemic: Using machine learning to measure twitter users' perceptions. Int J Med Inform. 2021 01; 145:104340. PMID: 33242762; PMCID: PMC7654388.
    Citations: 4     Fields:    Translation:HumansCellsPHPublic Health
  22. Jalali MS, DiGennaro C, Sridhar D. Transparency assessment of COVID-19 models. Lancet Glob Health. 2020 12; 8(12):e1459-e1460. PMID: 33125915.
    Citations: 9     Fields:    Translation:HumansCellsPHPublic Health
  23. Beaulieu E, DiGennaro C, Stringfellow E, Connolly A, Hamilton A, Hyder A, Cerdá M, Keyes KM, Jalali MS. Economic Evaluation in Opioid Modeling: Systematic Review. Value Health. 2021 02; 24(2):158-173. PMID: 33518022; PMCID: PMC7864393.
    Citations: 4     Fields:    Translation:HumansPHPublic Health
  24. Jalali MS, Botticelli M, Hwang RC, Koh HK, McHugh RK. The opioid crisis: need for systems science research. Health Res Policy Syst. 2020 Aug 08; 18(1):88. PMID: 32771004.
    Citations: 7     Fields:    Translation:HumansPHPublic Health
  25. Jalali MS, Botticelli M, Hwang RC, Koh HK, McHugh RK. The opioid crisis: a contextual, social-ecological framework. Health Res Policy Syst. 2020 Aug 06; 18(1):87. PMID: 32762700.
    Citations: 17     Fields:    Translation:HumansPHPublic Health
  26. Li P, Liu X, Mason E, Hu G, Zhou Y, Li W, Jalali MS. How telemedicine integrated into China's anti-COVID-19 strategies: case from a National Referral Center. BMJ Health Care Inform. 2020 Aug; 27(3). PMID: 32830110.
    Citations: 13     Fields:    Translation:HumansCellsPHPublic Health
  27. Li P, Luo Y, Yu X, Wen J, Mason E, Li W, Jalali MS. Patients' Perceptions of Barriers and Facilitators to the Adoption of E-Hospitals: Cross-Sectional Study in Western China. J Med Internet Res. 2020 06 11; 22(6):e17221. PMID: 32525483; PMCID: PMC7317627.
    Citations: 6     Fields:    Translation:Humans
  28. Namin AT, Vahdat V, DiGennaro C, Amid R, Jalali MS. Adoption of new medical technologies: The effects of insurance coverage vs continuing medical education. Health Policy and Technology. 2020. View Publication.
  29. Jalali MS, Bruckes M, Westmattelmann D, Schewe G. Why Employees (Still) Click on Phishing Links: Investigation in Hospitals. J Med Internet Res. 2020 01 23; 22(1):e16775. PMID: 32012071; PMCID: PMC7005690.
    Citations: 10     Fields:    Translation:Humans
  30. Namin AT, Jalali MS, Vahdat V, Bedair HS, O'Connor MI, Kamarthi S, Isaacs JA. Adoption of New Medical Technologies: The Case of Customized Individually Made Knee Implants. Value Health. 2019 Apr; 22(4):423-430. PMID: 30975393.
    Citations: 6     Fields:    Translation:Humans
  31. Jalali MS, Razak S, Gordon W, Perakslis E, Madnick S. Health Care and Cybersecurity: Bibliometric Analysis of the Literature. J Med Internet Res. 2019 02 15; 21(2):e12644. PMID: 30767908; PMCID: PMC6396074.
    Citations: 12     Fields:    Translation:Humans
  32. Jalali MS, Russell B, Razak S, Gordon WJ. EARS to cyber incidents in health care. J Am Med Inform Assoc. 2019 01 01; 26(1):81-90. PMID: 30517701.
    Citations: 11     Fields:    
  33. Jalali MS, Rahmandad H, Bullock SL, Lee-Kwan SH, Gittelsohn J, Ammerman A. Dynamics of intervention adoption, implementation, and maintenance inside organizations: The case of an obesity prevention initiative. Soc Sci Med. 2019 03; 224:67-76. PMID: 30763824.
    Citations: 10     Fields:    Translation:Humans
  34. Azghandi R, Griffin J, Jalali MS. Minimization of Drug Shortages in Pharmaceutical Supply Chains: A Simulation-Based Analysis of Drug Recall Patterns and Inventory Policies. Complexity. 2018; (6348413). View Publication.
  35. Hosseinichimeh N, Wittenborn AK, Rick J, Jalali MS, Rahmandad H. Modeling and estimating the feedback mechanisms among depression, rumination, and stressors in adolescents. PLoS One. 2018; 13(9):e0204389. PMID: 30261010.
    Citations: 5     Fields:    Translation:Humans
  36. Jalali MS, Kaiser JP. Cybersecurity in Hospitals: A Systematic, Organizational Perspective. J Med Internet Res. 2018 05 28; 20(5):e10059. PMID: 29807882; PMCID: PMC5996174.
    Citations: 21     Fields:    Translation:Humans
  37. Jalali MS, Rahmandad H, Bullock SL, Ammerman A. Dynamics of Implementation and Maintenance of Organizational Health Interventions. Int J Environ Res Public Health. 2017 08 15; 14(8). PMID: 28809807.
    Citations: 4     Fields:    Translation:Humans
  38. Rahmandad H, Jalali MS, Paynabar K. A flexible method for aggregation of prior statistical findings. PLoS One. 2017; 12(4):e0175111. PMID: 28384282.
    Citations: 2     Fields:    
  39. Hashmi S, D'Ambrosio L, Diamond DV, Jalali MS, Finkelstein SN, Larson RC. Preventive behaviors and perceptions of influenza vaccination among a university student population. J Public Health (Oxf). 2016 Dec 02; 38(4):739-745. PMID: 28158761.
    Citations: 6     Fields:    Translation:HumansPHPublic Health
  40. Ghaffarzadegan N, Ebrahimvandi A, Jalali MS. A Dynamic Model of Post-Traumatic Stress Disorder for Military Personnel and Veterans. PLoS One. 2016; 11(10):e0161405. PMID: 27716776.
    Citations: 9     Fields:    Translation:Humans
  41. Jalali MS, Sharafi-Avarzaman Z, Rahmandad H, Ammerman AS. Social influence in childhood obesity interventions: a systematic review. Obes Rev. 2016 09; 17(9):820-32. PMID: 27138986.
    Citations: 11     Fields:    Translation:Humans
  42. Abdel-Hamid T, Ankel F, Battle-Fisher M, Gibson B, Gonzalez-Parra G, Jalali M, Kaipainen K, Kalupahana N, Karanfil O, Marathe A, Martinson B, McKelvey K, Sarbadhikari SN, Pintauro S, Poucheret P, Pronk N, Qian Y, Sazonov E, Van Oorschot K, Venkitasubramanian A, Murphy P. Public and health professionals' misconceptions about the dynamics of body weight gain/loss. Syst Dyn Rev. 2014 January-June; 30(1-2):58-74. PMID: 25620843; PMCID: PMC4300993.
    Citations: 5     
Local representatives can answer questions about the Profiles website or help with editing a profile or issues with profile data. For assistance with this profile: HMS/HSDM faculty should contact contactcatalyst.harvard.edu. For faculty or fellow appointment updates and changes, please ask your appointing department to contact HMS. For fellow personal and demographic information, contact HMS Human Resources at human_resourceshms.harvard.edu. For faculty personal and demographic information, contact HMS Office for Faculty Affairs at facappthms.harvard.edu.
Jalali's Networks
Click the
buttons for more information and interactive visualizations!
Concepts (133)
Co-Authors (16)
Similar People (60)
Same Department 
Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.